Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA

Stock Information for Spectral Medical Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Spectral Medical Inc

Spectral Medical Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.